» Articles » PMID: 8909649

The Impact of Depression on Smoking Cessation in Women

Overview
Journal Am J Prev Med
Specialty Public Health
Date 1996 Sep 1
PMID 8909649
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cigarette smoking poses unique, but preventable health risks to women. Identification of barriers to womens' quitting is essential to tailor interventions accordingly. Major depression, whether historical, current, or subsyndromal, may present unique challenges to women quitting smoking. Although several reviews discuss women and smoking in general, this review focuses exclusively on the role of depression in womens' smoking.

Objectives: The goals of this review are to (1) discuss and synthesize the current findings on the association between smoking and depression in women in general, and in particular subgroups of women (underserved, premenstrual, postpartum, menopausal), (2) discuss physician-assisted, pharmacologic, behavioral interventions for mood management, and (3) propose future avenues for intervention, research, and policy. IMPACT OF DEPRESSION: Major depression may influence smoking cessation in women because (1) depression is twice as common among women as men, (2) history of depression and negative affect have been associated with smoking treatment failure, (3) quitting smoking is especially difficult during certain phases of the reproductive cycle, phases that have also been associated with greater levels of dysphoria, and (4) subgroups of women who have a high risk of continuing to smoke (underserved, less educated, low SES) also have a high risk of developing depression.

Conclusions: Since many women who are depressed (or who have developed depression during prior quit attempts) may be less likely to seek formal cessation treatment, practitioners have a unique opportunity to persuade their patients to quit. We discuss patient-treatment matching.

Citing Articles

Enhancing long-term smoking abstinence among individuals with a history of cervical intraepithelial neoplasia or cervical cancer (Project ACCESS): protocol for a randomized clinical trial.

Vidrine J, Fennell B, Simmons V, Sutton S, Jones S, Woodward H BMC Public Health. 2023; 23(1):1284.

PMID: 37403057 PMC: 10318835. DOI: 10.1186/s12889-023-16189-3.


Comparison of an automated smartphone-based smoking cessation intervention versus standard quitline-delivered treatment among underserved smokers: protocol for a randomized controlled trial.

Vidrine J, Shih Y, Businelle M, Sutton S, Hoover D, Cottrell-Daniels C BMC Public Health. 2022; 22(1):563.

PMID: 35317789 PMC: 8939152. DOI: 10.1186/s12889-022-12840-7.


Evaluating the Efficacy of Automated Smoking Treatment for People With HIV: Protocol for a Randomized Controlled Trial.

Vidrine D, Bui T, Businelle M, Shih Y, Sutton S, Shahani L JMIR Res Protoc. 2021; 10(11):e33183.

PMID: 34787590 PMC: 8663670. DOI: 10.2196/33183.


Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.

Nollen N, Ahluwalia J, Cox L, Okuyemi K, Lawrence D, Samuels L JAMA Netw Open. 2021; 4(1):e2032053.

PMID: 33464316 PMC: 7816102. DOI: 10.1001/jamanetworkopen.2020.32053.


Factors That Explain Differences in Abstinence Between Black and White Smokers: A Prospective Intervention Study.

Nollen N, Mayo M, Cox L, Benowitz N, Tyndale R, Ellerbeck E J Natl Cancer Inst. 2019; 111(10):1078-1087.

PMID: 30657926 PMC: 6792072. DOI: 10.1093/jnci/djz001.